Your session is about to expire
← Back to Search
Trier Social Stress Task (TSST) for Cannabis Use (PUMA Trial)
PUMA Trial Summary
This trial will study how cannabis affects memory, thinking skills, and stress response in older adults, as well as how it relates to Alzheimer's Disease biomarkers. The study is recruiting regular cannabis users ages 50-80, and participation will last approximately two weeks.
- Cannabis Use
PUMA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PUMA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are recruitment efforts still ongoing for this research project?
"Correct, the trial is still open for recruitment according to the latest information on clinicaltrials.gov. This study was first posted on November 19th 2021 and was edited most recently on January 7th, 2022. At the moment, the plan is to have 40 people total participate across 1 location."
Can people over 20 years old participate in this test?
"This trial is only open to patients that are between the ages of 50 to 80, as stipulated in the eligibility requirements."
Might I be eligible to help test this new medication?
"This trial is seeking 40 individuals aged 50-80 who are currently hashish users. In addition to being willing to abstain from other drugs for the study's duration, patients must also have functional visual and auditory acuity."
Share this study with friends
Copy Link
Messenger